Laffer Tengler Investments’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,974
Closed -$69.6K 422
2023
Q3
$69.6K Hold
1,974
0.02% 196
2023
Q2
$75K Sell
1,974
-243
-11% -$9.69K 0.02% 273
2023
Q1
$83.7K Sell
2,217
-24
-1% -$923 0.02% 276
2022
Q4
$95K Sell
2,241
-32
-1% -$1.32K 0.03% 262
2022
Q3
$73K Sell
2,273
-25
-1% -$878 0.03% 235
2022
Q2
$74.7K Sell
2,298
-2,835
-55% -$91.9K 0.03% 235
2022
Q1
$186K Sell
5,133
-2,055
-29% -$70.5K 0.06% 195
2021
Q4
$284K Sell
7,188
-294
-4% -$12.3K 0.08% 171
2021
Q3
$327K Buy
7,482
+1,708
+30% +$76.7K 0.09% 167
2021
Q2
$236K Buy
5,774
+418
+8% +$16.1K 0.09% 154
2021
Q1
$176K Buy
5,356
+1,458
+37% +$54.8K 0.07% 164
2020
Q4
$159K Buy
3,898
+895
+30% +$33.5K 0.07% 167
2020
Q3
$110K Hold
3,003
0.06% 166
2020
Q2
$102K Buy
+3,003
New +$81.8K 0.06% 155

Other funds holding GMAB

Laffer Tengler Investments's GMAB Position: Q4 2023 in Review

Laffer Tengler Investments sold out of Genmab (GMAB) in Q4 2023, closing a stake of 1,974 shares — an estimated $69.6K sold.

Laffer Tengler Investments first reported a position in GMAB in Q2 2020 and held it in 14 quarters. The position peaked at $327K in Q3 2021. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Laffer Tengler Investments reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Laffer Tengler Investments sold 1,974 Genmab shares in Q4 2023, an estimated $69.6K.
  • Laffer Tengler Investments first reported a position in Genmab in Q2 2020 and held it in 14 quarters.
  • Laffer Tengler Investments's Genmab position peaked at $327K in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Laffer Tengler Investments's 13F filing for Q4 2023, filed 8 Feb 2024.